Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Birch Pollen Immunotherapy for Oral Allergy Syndrome
NCT01431859Phase 4Unknown
- Sponsor
- Royal Sussex County Hospital
- Start
- Jul 2012
- Primary completion
- Nov 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of birch pollen allergoid in oral allergy syndrome (OAS), allergic rhinitis (AR), sponsored by Royal Sussex County Hospital. Status: unknown.
02
Drugs
birch pollen allergoid
03
Conditions
oral allergy syndrome (OAS)allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT01431859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01431859.